CA125 effects on humoral immunosuppression

Aging (Albany NY). 2017 Oct 3;9(10):2010-2011. doi: 10.18632/aging.101301.
No abstract available

Keywords: ADCC; CA125; farletuzumab; humoral immunosuppression; ovarian cancer.

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Biomarkers, Tumor
  • CA-125 Antigen*
  • Female
  • Humans
  • Immunity, Humoral
  • Immunosuppression Therapy*
  • Immunosuppressive Agents / pharmacology*
  • Neoplasms / immunology
  • Neoplasms / metabolism*

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • CA-125 Antigen
  • Immunosuppressive Agents
  • farletuzumab